The core team comes from top German research institutions, leads major BMBF projects, and has been deeply engaged in EIT technology for over 10 years.

A total of 26 applications (including 5 authorized invention patents, 4 utility model patents, and 1 software copyright) have been filed, and 5 patents related to thoracic electrical impedance perfusion have been authorized by Peking Union Medical College Hospital. The company has participated in the translation of the international monograph "Electrical Impedance Tomography" and led the development of industry standards.

• The lung electrical impedance tomograph (developed by the subsidiary Beijing MidasMED) has been approved for registration as a Class II medical device (Yuexie) and is accelerating clinical promotion.

• Covers ICU, perioperative, and rehabilitation scenarios, including new functional instruments with EIT functions, portable lung electrical impedance imaging, new high-speed oxygen therapy instruments with EIT functions, and a series of EIT rehabilitation instruments, realizing full-process monitoring, evaluation, and treatment.

• Real-time dynamic presentation of ventilation/blood flow distribution, AI-assisted diagnostic system improves clinical decision-making efficiency by 40%, and has been verified by authoritative institutions such as Peking Union Medical College Hospital and Shanghai Renji Hospital.

• In 2024, a joint application for a National Natural Science Foundation of China project will be submitted to develop an intelligent monitoring device for sleep apnea.

Leading emergency response projects of the Guangzhou National Laboratory (EKPG21-17), national key R&D plans, and establishing joint laboratories with the Chinese Academy of Sciences.

More than 3,000 cases of patient data have been collected through joint research with universities and hospitals, and more than 20 SCI papers have been published to accelerate the transformation of scientific research achievements.